Continuous manufacturing in pharmaceuticals: an integrated approach with NIR and Raman as PAT tools

In the past few decades, the global pharmaceutical sector has experienced increasing pressure to enhance efficiency, as production costs have risen faster than the rate of new drug development. However, the pharmaceutical manufacturing framework primarily remains unchanged and still relies on batch manufacturing. In contrast, the current regulatory landscape promotes advancements in manufacturing, potentially replacing some traditional manufacturing methods with cleaner, more adaptable, and more efficient continuous manufacturing (CM) techniques. CM provides numerous benefits over conventional batch processing, including faster production, cost savings, greater flexibility, and significantly enhanced quality assurance. The integration of Process Analytical Technology (PAT) in CM facilitates real-time evaluation and process regulation, maintaining consistent product quality. PAT operates on the principle that product quality should be ensured throughout the manufacturing process rather than verified only through post-production testing. Raman and NIR spectroscopy are of great importance in CM because they provide rapid, non-destructive, and often inline evaluation by eliminating the necessity for sample preparation. These spectroscopic techniques enhance process efficiency and quality control by providing real-time chemical and physical insights. Their application in CM has grown significantly, contributing to a deeper understanding of process dynamics and improving manufacturing outcomes. As a result, numerous studies have been conducted in various areas of pharmaceutical technology, emphasizing the advancement in the CM of drug substances and products. Real-time assessment using NIR and Raman has been crucial in optimizing these processes, enhancing efficiency, and ensuring product quality. This review presents a comprehensive summary of the implementation of Raman and NIR spectroscopy in CM, covering primary, secondary, and end-to-end operations.